Drug-labels.com

Act Donepezil ODT: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx) Current status: Cancelled Post Market
Strength:
5 mg, 10 mg
ATC code:

Patient Medication Information: uses, side effects, how to take - Act Donepezil ODT

ABOUT THIS MEDICATION

What the medication is used for:

This medicine is called ACT DONEPEZIL ODT (which contains donepezil hydrochloride).

Donepezil hydrochloride is one of a group of drugs called “cholinesterase inhibitors”

ACT DONEPEZIL ODT is used for the symptomatic treatment of mild, moderate, and severe Alzheimer’s disease.

ACT DONEPEZIL ODT can only be obtained with a prescription from a doctor.

What it does:

In the brains of persons with Alzheimer’s disease, there is a decrease in the function of a neurotransmitter system which uses acetylcholine as its chemical messenger.

ACT DONEPEZIL ODT acts by inhibiting an enzyme called acetylcholinesterase, leading to an increase in the level of acetylcholine in the brain, which may help relieve the symptoms of Alzheimer’s disease.

In clinical studies, patients treated with donepezil hydrochloride showed improvement, remained unchanged, or declined more slowly as compared to patients who received a placebo (sugar tablet). Benefits were seen in memory and other mental functions, as well as in the ability to perform daily activities.

ACT DONEPEZIL ODT may take as long as 12 weeks to begin working, and patient response to this medicine will vary.

When it should not be used:

  • If you are allergic to this medicine, any of its inactive ingredients (see the section “What the important nonmedicinal ingredients are”), or to piperidine derivatives such as Mycobutin (rifabutin), Ritalin (methylphenidate),

    • Akineton (biperiden HCl), trihexyphenidyl, bupivacaine, and Paxil (paroxetine HCl).

What the medicinal ingredient is:

ACT DONEPEZIL ODT contains donepezil hydrochloride.

What the important nonmedicinal ingredients are:

ACT DONEPEZIL ODT contains the following inactive ingredients: colloidal silica anhydrous, crospovidone, mannitol, natural peppermint, saccharin sodium, sodium stearyl fumarate and sorbitol.

What dosage forms it comes in:

ACT DONEPEZIL ODT is available as orally disintegrating tablets. The 5 mg and 10 mg tablets are white to off-white.

WARNINGS AND PRECAUTIONS

Tell your doctor if you have any muscle pain, tenderness, soreness or weakness, especially if you also have a fever, during treatment with ACT DONEPEZIL.

SERIOUS SIDE EFFECTS, HOW OFTEN THEY HAPPEN AND WHAT TO DO ABOUT THEM
Symptom / effectTalk with your doctor or pharmacistStop taking drug and seek immediate medical help
Only if severeIn all cases
RareRhabdomyolysis: combination of muscle pain, tenderness, or weakness, or joint pain accompanied by a fever or very dark urine that you cannot explainX
Very RareNeuroleptic Malignant Syndrome: A state of high fever, muscle stiffness, irregular blood pressure, pulse and or heartbeats, altered consciousnessX

BEFORE you use ACT DONEPEZIL ODT talk to your doctor or pharmacist if:

  • You are taking other medicines, including prescription drugs or products that you can buy without a prescription, such as herbal (natural) products.
  • You have a condition affecting your heart, kidney, liver or your lungs, such as asthma or obstructive pulmonary disease.
  • You have had seizures.
  • You have had fainting spells.
  • You have a history of peptic ulcers or have an increased risk of developing ulcers (for example, if you are taking nonsteroidal anti-inflammatory drugs [NSAIDS] or high doses of acetylsalicylic acid [ASA] [Aspirin®]).
  • If you are pregnant or breastfeeding.

  • An operation with a general anesthetic is needed, inform your doctor about the use of ACT DONEPEZIL ODT.

PROPER USE OF THIS MEDICATION

This medication should only be taken after proper diagnosis of your condition has been made by your doctor.

  • In order to obtain the best results from ACT DONEPEZIL ODT, it must be taken every day, exactly as prescribed by your doctor. Never change the dose yourself.
  • Take ACT DONEPEZIL ODT once daily, at the same time every day, in the morning or evening.
  • Take ACT DONEPEZIL ODT with or without food.

ACT DONEPEZIL ODT should be placed on the tongue and allowed to disintegrate before swallowing with water.

A Reminder: This medicine has been prescribed only for you or for the person you are caring for. Never give it to anyone else.

Overdose:

In case of drug overdose, contact a healthcare practitioner, hospital emergency department or regional Poison Control Centre immediately, even if there are no symptoms.

Missed Dose:

If you miss taking a dose of ACT DONEPEZIL ODT do not worry, just take the next dose when it is due. Do NOT take 2 doses at once.

If you have problems remembering to take medications, it may be necessary to have someone help you.

SIDE EFFECTS AND WHAT TO DO ABOUT THEM

Along with its beneficial effect, ACT DONEPEZIL ODT may cause some undesirable reactions. The most common side effects include nausea (feeling sick) and diarrhea. In clinical studies, these effects were often mild, and generally went away with continued treatment. If they persist you should tell your doctor.

Other possible side effects include:

  • insomnia (difficulty sleeping)
  • vomiting (being sick)
  • muscle cramps
  • fatigue
  • anorexia (loss of appetite)
  • fainting

If you feel unwell in any other way or have any symptoms that you do not understand, or find distressing, you should contact your doctor immediately. If you experience severe adverse events, stop taking the drug until you can discuss your symptoms with your doctor

This is not a complete list of side effects. For any unexpected effects while taking ACT DONEPEZIL ODT, contact your doctor or pharmacist.

HOW TO STORE IT

Keep this medicine in a safe place, out of reach of children.

Keep ACT DONEPEZIL ODT in a cool dry place (15 to 30°C) and avoid exposure to moisture.

ACT DONEPEZIL ODT is also sensitive to light and should not be removed from blisters until immediately prior to administration. Protect from light.

REPORTING SUSPECTED SIDE EFFECTS

You can report any suspected adverse reactions associated with the use of health products to the Canada Vigilance Program by one of the following 3 ways:

------------------------------------------------------------------------------

  • Report online at www.healthcanada.gc.ca/medeffect
  • Call toll-free at 1-866-234-2345
  • Complete a Canada Vigilance Reporting Form and:

    • Fax toll-free to 1-866-678-6789, or
    • Mail to: Canada Vigilance Program

      Health Canada

      Postal Locator 0701E

      Ottawa, ON K1A 0K9

Postage paid labels, Canada Vigilance Reporting Form and the adverse reaction reporting guidelines are available on the MedEffect™ Canada Web site at www.healthcanada.gc.ca/medeffect.

------------------------------------------------------------------------------

NOTE: Should you require information related to the management of side effects, contact your health professional. The Canada Vigilance Program does not provide medical advice.

MORE INFORMATION

This document plus the full product monograph, prepared for health professionals can be found by contacting the sponsor, Teva Canada Limited by;

Phone: 1-800-268-4127 ext. 3;

Email: druginfo@tevacanada.com; or

Fax: 1-416-335-4472

Teva Canada Limited

30 Novopharm Court

Toronto, Ontario

M1B 2K9

Date revised: January 22, 2018

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02397617

Revision date stated in the text: January 22, 2018

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Act Donepezil ODT

Rx or OTC
Prescription (Rx)?
DIN 02397617, 02397625
Schedule(s) PRESCRIPTION
Active ingredient(s) Donepezil hydrochloride (donepezil hydrochloride monohydrate)
Dosage form(s) Tablet (Orally-Disintegrating)
Route(s) of administration Oral
Drug class (WHO ATC)
  1. N Nervous system drugs
    1. N06 Psychoanaleptics
      1. N06D Anti-dementia drugs
        1. N06DA Anticholinesterase anti-dementia drugs
          1. N06DA02 Donepezil
Company TEVA CANADA LIMITED
Current status Cancelled Post Market
Current status date May 30, 2022
Strengths and forms
DIN Strength Dosage form(s) Current status
02397617 5 MG Tablet (Orally-Disintegrating) Cancelled Post Market May 30, 2022
02397625 10 MG Tablet (Orally-Disintegrating) Cancelled Post Market May 30, 2022

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.